Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 365.0 $ 113.0
Restricted cash and cash equivalents 5.0 5.0
Restricted cash and cash equivalents - Asbestos 45.8 67.6
Restricted short-term investments - Asbestos 178.4 140.9
Accounts and other receivables, net 366.1 354.8
Inventories 337.8 344.2
Prepaid expenses and other current assets 68.2 41.0
Assets held for sale 55.4 0.0
Insurance receivable - Asbestos 5.1 6.8
Workers’ compensation - Asbestos 1.6 1.8
Total current assets 1,428.4 1,075.1
Property, plant and equipment, net 2,037.8 1,839.6
Operating lease right-of-use-assets 60.9 59.4
Goodwill 192.6 194.9
Intangible assets, net 149.2 155.2
Restricted long-term investments - Asbestos 0.0 36.2
Insurance receivable - Asbestos 26.4 28.2
Workers’ compensation - Asbestos 13.6 16.4
Deferred income taxes 690.4 755.6
Deferred income taxes - Asbestos 294.0 298.6
Other assets 19.3 19.9
Total assets 4,912.6 4,479.1
Current liabilities:    
Accounts payable and accrued liabilities 463.3 387.7
Accrued payroll and employee benefits 143.3 108.3
Operating lease liabilities 19.0 18.1
Long-term debt, current portion 7.5 0.0
Accrued product warranties 7.3 5.4
Income taxes payable 13.0 15.4
Asbestos liability 116.7 119.4
Workers’ compensation - Asbestos 1.6 1.8
Other liabilities 26.0 41.2
Total current liabilities 797.7 697.3
Long-term debt 1,115.1 1,059.0
Deferred income taxes 107.5 93.6
Operating lease liabilities 59.4 61.1
Accrued product warranties 28.9 30.2
Income taxes payable 0.0 2.3
Asbestos liability 873.0 857.7
Workers’ compensation - Asbestos 13.6 16.4
Other liabilities 58.5 50.1
Total liabilities 3,053.7 2,867.7
Commitments and contingencies (Note 14)
Shareholders’ equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 433,784,634 shares issued and outstanding at 31 March 2024 and 442,056,296 shares issued and outstanding at 31 March 2023 224.7 230.0
Additional paid-in capital 256.5 237.9
Retained earnings 1,446.0 1,196.8
Accumulated other comprehensive loss (68.3) (53.3)
Total shareholders’ equity 1,858.9 1,611.4
Total liabilities and shareholders’ equity $ 4,912.6 $ 4,479.1